Alfio José Tincani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alfio José Tincani has a total of 312 co-authors. Here are the top co-authors by number of shared publications:
Antonio Santos Martins
Head and Neck Surgery Service, Department of Surgery, School of Medical Sciences, Universidade Estadual de Campinas, Campinas, Brazil
14 shared publicationsAlbina Altemani
Department of Oral Diagnosis, Piracicaba Dental School University of Campinas (UNICAMP) Piracicaba Brazil
13 shared publications- Fernanda Viviane Mariano
Department of Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas 13083-970, SP, Brazil
13 shared publications André Del Negro
Head and Neck Surgery Service, Department of Surgery, School of Medical Sciences, Universidade Estadual de Campinas, Campinas, Brazil
10 shared publications- Albina Altemani
Pathology Department, Faculdade de Ciências Médicas, Universidade Estadual de Campinas, Campinas, SP, Brazil
7 shared publications Gilson Barreto
Centro Médico de Campinas, Campinas, SP, Brazil
7 shared publications
Latest Publications
- Open Access
- 17 March 2026
- Published by Wiley in Oral Diseases
- Vol. 32 (7) , 1923-1937
Clinicopathological and Prognostic Features of Pleomorphic Adenoma, Recurrent Pleomorphic Adenoma, and Carcinoma ex Pleomorphic Adenoma: A 20‐Year Retrospective Analysis
Background: Pleomorphic adenoma (PA) is the most common salivary gland tumor, and a subset may recur as recurrent PA (RPA) or progress to carcinoma ex pleomorphic adenoma (CXPA). However, comparative evaluations of their biological behavior and prognostic factors remain limited. Objective: To characterize and compare the clinical features, pathological patterns, treatment outcomes, and prognostic factors of PA, RPA, and CXPA over a 20‐year period at a Brazilian tertiary referral center. Materials and Methods: A retrospective review of 234 cases (148 PA, 23 RPA, 63 CXPA) diagnosed between 2004 and 2024. Analyses included Fisher's exact test and chi‐square test for group comparisons and Cox proportional hazards models for overall (OS) and disease‐specific survival (DSS). Results: PA and RPA mainly affected younger females and presented smaller tumors and shorter clinical evolution than CXPA ( p < 0.01). In CXPA, perineural invasion, angiolymphatic invasion, necrosis, recurrence, symptomatology, distant metastasis, and capsular invasion pattern were associated with reduced OS and DSS ( p < 0.05). Conclusion: This retrospective study demonstrates distinct clinical and pathological profiles across PA, RPA, and CXPA. In CXPA, clinical and histological factors strongly predict survival and should guide risk stratification, therapeutic decisions, and follow‐up strategies.
- 17 March 2026
- Published by Wiley in Oral Diseases
- Vol. 32 (7) , 1923-1937
Open AccessClinicopathological and Prognostic Features of Pleomorphic Adenoma, Recurrent Pleomorphic Adenoma, and Carcinoma ex Pleomorphic Adenoma: A 20‐Year Retrospective Analysis
Background: Pleomorphic adenoma (PA) is the most common salivary gland tumor, and a subset may recur as recurrent PA (RPA) or progress to carcinoma ex pleomorphic adenoma (CXPA). However, comparative evaluations of their biological behavior and prognostic factors remain limited. Objective: To characterize and compare the clinical features, pathological patterns, treatment outcomes, and prognostic factors of PA, RPA, and CXPA over a 20‐year period at a Brazilian tertiary referral center. Materials and Methods: A retrospective review of 234 cases (148 PA, 23 RPA, 63 CXPA) diagnosed between 2004 and 2024. Analyses included Fisher's exact test and chi‐square test for group comparisons and Cox proportional hazards models for overall (OS) and disease‐specific survival (DSS). Results: PA and RPA mainly affected younger females and presented smaller tumors and shorter clinical evolution than CXPA ( p < 0.01). In CXPA, perineural invasion, angiolymphatic invasion, necrosis, recurrence, symptomatology, distant metastasis, and capsular invasion pattern were associated with reduced OS and DSS ( p < 0.05). Conclusion: This retrospective study demonstrates distinct clinical and pathological profiles across PA, RPA, and CXPA. In CXPA, clinical and histological factors strongly predict survival and should guide risk stratification, therapeutic decisions, and follow‐up strategies.
- 24 December 2025
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 127 (3) , 102695
Clinicopathological analysis and survival outcomes of head and neck spindle cell carcinoma: A systematic review
- 24 December 2025
- Published by Elsevier in Journal of Stomatology Oral and Maxillofacial Surgery
- Vol. 127 (3) , 102695
Clinicopathological analysis and survival outcomes of head and neck spindle cell carcinoma: A systematic review
- 20 October 2025
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 217, 104982
Impact of elective cervical dissection on the prognosis of patients with oral squamous cell carcinoma cT1/T2N0: A systematic review and meta-analysis
- 20 October 2025
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 217, 104982
Impact of elective cervical dissection on the prognosis of patients with oral squamous cell carcinoma cT1/T2N0: A systematic review and meta-analysis
- Open Access
- 30 September 2025
- Published by Wiley in Oral Diseases
- Vol. 32 (2) , 338-349
Clinicopathologic Analysis of Sarcomas in the Oral and Maxillofacial Region: A Systematic Review
Objective: This study aimed to systematically review primary sarcomas in the oral and maxillofacial region, focusing on patient demographics and sarcoma‐specific characteristics, including clinical presentation, histopathology, treatment approaches, outcomes, and survival rates. Materials and Methods: A systematic review was conducted in accordance with PRISMA 2020 guidelines and based on the PECOS framework, including observational studies on primary oral and maxillofacial sarcomas. An electronic search in five databases identified eligible studies, and outcomes were analyzed via Kaplan–Meier and Cox regression. Results: The review included 35 studies comprising 687 cases of sarcomas in the oral and maxillofacial region. The mean patient age was 35.26 years, with a slight male predominance. Lesions predominantly involved the mandible, with osteosarcoma being the most common histological subtype. Multimodal treatment was most frequent. Of 616 patients with survival data, 58.1% were alive at analysis. The overall 5‐year survival and disease‐free survival rates were 54.3% and 60.4%, respectively. Factors such as age, histological type, T classification, stage grouping, surgical margins, local recurrence, and distant metastases significantly influenced survival ( p < 0.05). Conclusion: This study provides a comprehensive review of oral and maxillofacial sarcomas, offering data to understand the clinicopathological characteristics of these lesions, helping to improve their diagnosis and management.
- 30 September 2025
- Published by Wiley in Oral Diseases
- Vol. 32 (2) , 338-349
Open AccessClinicopathologic Analysis of Sarcomas in the Oral and Maxillofacial Region: A Systematic Review
Objective: This study aimed to systematically review primary sarcomas in the oral and maxillofacial region, focusing on patient demographics and sarcoma‐specific characteristics, including clinical presentation, histopathology, treatment approaches, outcomes, and survival rates. Materials and Methods: A systematic review was conducted in accordance with PRISMA 2020 guidelines and based on the PECOS framework, including observational studies on primary oral and maxillofacial sarcomas. An electronic search in five databases identified eligible studies, and outcomes were analyzed via Kaplan–Meier and Cox regression. Results: The review included 35 studies comprising 687 cases of sarcomas in the oral and maxillofacial region. The mean patient age was 35.26 years, with a slight male predominance. Lesions predominantly involved the mandible, with osteosarcoma being the most common histological subtype. Multimodal treatment was most frequent. Of 616 patients with survival data, 58.1% were alive at analysis. The overall 5‐year survival and disease‐free survival rates were 54.3% and 60.4%, respectively. Factors such as age, histological type, T classification, stage grouping, surgical margins, local recurrence, and distant metastases significantly influenced survival ( p < 0.05). Conclusion: This study provides a comprehensive review of oral and maxillofacial sarcomas, offering data to understand the clinicopathological characteristics of these lesions, helping to improve their diagnosis and management.
- Open Access
Association of Fibrinolytic Potential and Risk of Mortality in Cancer Patients
Cancer is a leading cause of death, and the fibrinolytic system shows cooperative effects that facilitate the growth of tumors and the appearance of metastases. This prospective study aimed to evaluate the fibrinolytic potential in cancer patients and its association with mortality outcomes using the fluorometric method of simultaneous thrombin and plasmin generation. The study included 323 cancer patients and 148 healthy individuals. During the 12-month follow-up, 68 patients died. Compared to the control group, cancer patients showed alterations in thrombin production consistent with a hypercoagulability profile, and an increase in plasmin generation. Mortality risk was associated with two parameters of thrombin in both univariate and multivariable analysis: maximum amplitude (Wald 11.78, p < 0.001) and area under the curve (Wald 8.0, p < 0.005), while such associations were not observed for plasmin. In conclusion, this was the first study able to demonstrate the simultaneous evaluation of thrombin and plasmin generation in newly diagnosed untreated cancer patients. Patients with cancer have been observed to exhibit a hypercoagulable profile. During the study, two parameters linked to thrombin generation, MA and AUC, were identified and found to have a potential association with mortality risk. However, no associations were found with parameters related to plasmin generation.
Open AccessAssociation of Fibrinolytic Potential and Risk of Mortality in Cancer Patients
Cancer is a leading cause of death, and the fibrinolytic system shows cooperative effects that facilitate the growth of tumors and the appearance of metastases. This prospective study aimed to evaluate the fibrinolytic potential in cancer patients and its association with mortality outcomes using the fluorometric method of simultaneous thrombin and plasmin generation. The study included 323 cancer patients and 148 healthy individuals. During the 12-month follow-up, 68 patients died. Compared to the control group, cancer patients showed alterations in thrombin production consistent with a hypercoagulability profile, and an increase in plasmin generation. Mortality risk was associated with two parameters of thrombin in both univariate and multivariable analysis: maximum amplitude (Wald 11.78, p < 0.001) and area under the curve (Wald 8.0, p < 0.005), while such associations were not observed for plasmin. In conclusion, this was the first study able to demonstrate the simultaneous evaluation of thrombin and plasmin generation in newly diagnosed untreated cancer patients. Patients with cancer have been observed to exhibit a hypercoagulable profile. During the study, two parameters linked to thrombin generation, MA and AUC, were identified and found to have a potential association with mortality risk. However, no associations were found with parameters related to plasmin generation.
- 15 June 2023
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 136 (1) , e74-e75
MAXILLOFACIAL DIPROSOPUS: AN EXTREMELY RARE CONGENITAL ANOMALY AND ITS SURGICAL MANAGEMENT
- 15 June 2023
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 136 (1) , e74-e75
MAXILLOFACIAL DIPROSOPUS: AN EXTREMELY RARE CONGENITAL ANOMALY AND ITS SURGICAL MANAGEMENT
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 50, e20233521
Avaliação da carga do tumor em linfonodo sentinela nos doentes portadores de melanoma cutâneo
Cutaneous melanoma (MC) is a malignant neoplasm derived from melanocytic cells with an aggressive behavior. It is usually associated with the multifactorial interaction of genetic susceptibility and environmental exposure, usually ultraviolet radiation. Despite advances in treatment, the disease remains relentless with poor prognosis. Sentinel lymph node (SLN) biopsy is a technique used to screen patients in need of lymph node dissection.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 50, e20233521
Open AccessAvaliação da carga do tumor em linfonodo sentinela nos doentes portadores de melanoma cutâneo
Cutaneous melanoma (MC) is a malignant neoplasm derived from melanocytic cells with an aggressive behavior. It is usually associated with the multifactorial interaction of genetic susceptibility and environmental exposure, usually ultraviolet radiation. Despite advances in treatment, the disease remains relentless with poor prognosis. Sentinel lymph node (SLN) biopsy is a technique used to screen patients in need of lymph node dissection.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 50, e20233521
Evaluation of tumor load in sentinel lymph node in patients with cutaneous melanoma
Cutaneous melanoma (MC) is a malignant neoplasm derived from melanocytic cells with an aggressive behavior. It is usually associated with the multifactorial interaction of genetic susceptibility and environmental exposure, usually ultraviolet radiation. Despite advances in treatment, the disease remains relentless with poor prognosis. Sentinel lymph node (SLN) biopsy is a technique used to screen patients in need of lymph node dissection.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Revista do Colégio Brasileiro de Cirurgiões
- Vol. 50, e20233521
Open AccessEvaluation of tumor load in sentinel lymph node in patients with cutaneous melanoma
Cutaneous melanoma (MC) is a malignant neoplasm derived from melanocytic cells with an aggressive behavior. It is usually associated with the multifactorial interaction of genetic susceptibility and environmental exposure, usually ultraviolet radiation. Despite advances in treatment, the disease remains relentless with poor prognosis. Sentinel lymph node (SLN) biopsy is a technique used to screen patients in need of lymph node dissection.
- Open Access
- 18 December 2021
- Published by Elsevier in Brazilian Journal of Anesthesiology (English Edition)
- Vol. 72 (3) , 428-431
Experimental model for local anesthetic spread in spinal anesthesia: application to medical education
- 18 December 2021
- Published by Elsevier in Brazilian Journal of Anesthesiology (English Edition)
- Vol. 72 (3) , 428-431
Open AccessExperimental model for local anesthetic spread in spinal anesthesia: application to medical education
- 13 December 2021
- Published by Wiley in Oral Diseases
- Vol. 29 (3) , 1017-1027
Discovery proteomics reveals potential protein signature associated with malignant phenotype acquisition in pleomorphic adenoma
Objective: To analyze the proteomic profile of salivary pleomorphic adenoma (PA) and carcinoma ex pleomorphic adenoma (CXPA) samples and correlate them with the malignant transformation of the PA.Materials and methods: Thirty samples (10 PA, 16 CXPA, and 4 residual PA) were microdissected and submitted to liquid chromatography‐tandem mass spectrometry (LC‐MS/MS). The proteomic data and protein identification were analyzed through LC‐MS/MS spectra using the MaxQuant software.Results: The proteomic analysis identified and quantified a total of 240 proteins in which 135 were found in PA, residual PA, and CXPA. The shared proteins were divided into six subgroups, and the proteins that showed statistically significant differences (p > 0.05) and fold‐change > or <2.5 in one subgroup to another subgroup were included. Seven proteins (Apolipoprotein A‐I—APOA1, haptoglobin—HP, protein of the synaptonemal complex 1—SYCP1, anion transport protein of band 3—SLC4A1, subunit μ1 of AP‐1 complex—AP1M1, beta subunit of hemoglobin—HBB, and dermcidin—DCD) were classified as potential protein signatures, being HP, AP1M1, and HBB with higher abundance for PA to residual PA, APOA1 with higher abundance for PA to CXPA, SLC4A1 with lower abundance in the PA to CXPA, SYCP1with lower abundance for residual PA to CXPA, and DCD with higher abundance in the CXPA with epithelial differentiation to myoepithelial differentiation.Conclusions: In this work, we demonstrated the comparative proteomic profiling of PA, residual PA, and CXPA, and seven were proposed as protein signatures, some of which may be associated with the malignant phenotype acquisition.
- 13 December 2021
- Published by Wiley in Oral Diseases
- Vol. 29 (3) , 1017-1027
Discovery proteomics reveals potential protein signature associated with malignant phenotype acquisition in pleomorphic adenoma
Objective: To analyze the proteomic profile of salivary pleomorphic adenoma (PA) and carcinoma ex pleomorphic adenoma (CXPA) samples and correlate them with the malignant transformation of the PA.Materials and methods: Thirty samples (10 PA, 16 CXPA, and 4 residual PA) were microdissected and submitted to liquid chromatography‐tandem mass spectrometry (LC‐MS/MS). The proteomic data and protein identification were analyzed through LC‐MS/MS spectra using the MaxQuant software.Results: The proteomic analysis identified and quantified a total of 240 proteins in which 135 were found in PA, residual PA, and CXPA. The shared proteins were divided into six subgroups, and the proteins that showed statistically significant differences (p > 0.05) and fold‐change > or <2.5 in one subgroup to another subgroup were included. Seven proteins (Apolipoprotein A‐I—APOA1, haptoglobin—HP, protein of the synaptonemal complex 1—SYCP1, anion transport protein of band 3—SLC4A1, subunit μ1 of AP‐1 complex—AP1M1, beta subunit of hemoglobin—HBB, and dermcidin—DCD) were classified as potential protein signatures, being HP, AP1M1, and HBB with higher abundance for PA to residual PA, APOA1 with higher abundance for PA to CXPA, SLC4A1 with lower abundance in the PA to CXPA, SYCP1with lower abundance for residual PA to CXPA, and DCD with higher abundance in the CXPA with epithelial differentiation to myoepithelial differentiation.Conclusions: In this work, we demonstrated the comparative proteomic profiling of PA, residual PA, and CXPA, and seven were proposed as protein signatures, some of which may be associated with the malignant phenotype acquisition.